Operating Margin of Ovid Therapeutics Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Ovid Therapeutics Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Ovid Therapeutics Inc. Operating Margin for the quarter ending 30 Sep 2025 was -618%, a 94% increase year-over-year.
  • Ovid Therapeutics Inc. annual Operating Margin for 2024 was -10934%, a 28% increase from 2023.
  • Ovid Therapeutics Inc. annual Operating Margin for 2023 was -15123%, a 309% decline from 2022.
  • Ovid Therapeutics Inc. annual Operating Margin for 2022 was -3696%, a 6301% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Ovid Therapeutics Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -618% +10354% +94% 01 Jul 2025 30 Sep 2025
Q2 2025 -625% +11373% +95% 01 Apr 2025 30 Jun 2025
Q1 2025 -10405% +2634% +20% 01 Jan 2025 31 Mar 2025
Q4 2024 -10934% +4189% +28% 01 Oct 2024 31 Dec 2024
Q3 2024 -10973% +7005% +39% 01 Jul 2024 30 Sep 2024
Q2 2024 -11998% +15242% +56% 01 Apr 2024 30 Jun 2024
Q1 2024 -13039% +30868% +70% 01 Jan 2024 31 Mar 2024
Q4 2023 -15123% -11426% -309% 01 Oct 2023 31 Dec 2023
Q3 2023 -17978% 01 Jul 2023 30 Sep 2023
Q2 2023 -27241% 01 Apr 2023 30 Jun 2023
Q1 2023 -43907% 01 Jan 2023 31 Mar 2023
Q4 2022 -3696% 01 Oct 2022 31 Dec 2022

Ovid Therapeutics Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -10934% +4189% +28% 01 Jan 2024 31 Dec 2024
2023 -15123% -11426% -309% 01 Jan 2023 31 Dec 2023
2022 -3696% -3756% -6301% 01 Jan 2022 31 Dec 2022
2021 60% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.